Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' GUILHOT F' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 99 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Daheron, L; Veinstein, A; Brizard, F; Drabkin, H; Lacotte, L; Guilhot, F; Larsen, CJ; Brizard, A; Roche, J
      Human LPP gene is fused to MLL in a secondary acute leukemia with a t(3;11) (q28;q23)

      GENES CHROMOSOMES & CANCER
    2. Kitzis, A; Brizard, F; Dascalescu, C; Chomel, JC; Guilhot, F; Brizard, A
      Persistence of transcriptionally silent BCR-ABL rearrangements in chronic myeloid leukemia patients in sustained complete cytogenetic remission

      LEUKEMIA & LYMPHOMA
    3. Beck, JR; Guilhot, J; Giles, FJ; Aoki, N; Wirt, DP; Guilhot, F
      Cytarabine added to interferon improves the cost-effectiveness of initial therapy for patients with early chronic phase chronic myelogenous leukemia

      LEUKEMIA & LYMPHOMA
    4. Hunault-Berger, M; Milpied, N; Bernard, M; Jouet, JP; Delain, M; Desablens, B; Sadoun, A; Guilhot, F; Casassus, P; Ifrah, N
      Daunorubicin continuous infusion induces more toxicity than bolus infusionin acute lymphoblastic leukemia induction regimen: a randomized study

      LEUKEMIA
    5. Millot, F; Traore, P; Boinot, C; Vandermarcq, P; Sadoun, A; Brizard, A; Guilhot, F
      Hemianopsy revealing cerebral thrombosis: role of protein S deficiency induced by L-asparginase

      PRESSE MEDICALE
    6. Guilhot, F
      Anti-tyrosine kinase: first results of initial molecular therapies of cancer diseases

      BULLETIN DU CANCER
    7. Leblond, V; Levy, V; Maloisel, F; Cazin, B; Fermand, JP; Harousseau, JL; Remenieras, L; Porcher, R; Gardembas, M; Marit, G; Deconinck, E; Desablens, B; Guilhot, F; Philippe, G; Stamatoullas, A; Guibon, O
      Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenstrom macroglobulinemia in first relapse or with primary refractory disease

      BLOOD
    8. Bonifazi, F; de Vivo, A; Rosti, G; Guilhot, F; Guilhot, J; Trabacchi, E; Hehlmann, R; Hochhaus, A; Shepherd, PCA; Steegmann, JL; Kluin-Nelemans, HC; Thaler, J; Simonsson, B; Louwagie, A; Reiffers, J; Mahon, FX; Montefusco, E; Alimena, G; Hasford, J; Richards, S; Saglio, G; Testoni, N; Martinelli, G; Tura, S; Baccarani, M
      Chronic myeloid leukemia and interferon-alpha: a study of complete cytogenetic responders

      BLOOD
    9. Blaise, D; Maraninchi, D; Michallet, M; Reiffers, J; Jouet, JP; Milpied, N; Devergie, A; Attal, M; Sotto, JJ; Kuentz, M; Ifrah, N; Duriac, C; Bordigoni, P; Gratecos, N; Guilhot, F; Guyotat, D; Gluckman, E; Vernant, JP
      Long-term follow-up of a randomized trial comparing the combination of cyclophosphamide with total body irradiation or busulfan as conditioning regimen for patients receiving HLA-identical marrow grafts for acute myeloblastic leukemia in first complete remission

      BLOOD
    10. Harousseau, JL; Witz, B; Lioure, B; Hunault-Berger, M; Desablens, B; Delain, M; Guilhot, F; Le Prise, PY; Abgrall, JF; Deconinck, E; Guyotat, D; Vilque, JP; Casassus, P; Tournilhac, O; Audhuy, B; Solary, E
      Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: Results of a randomized trial of the Groupe Ouest-Est Leucemies Aigues Myeloblastiques

      JOURNAL OF CLINICAL ONCOLOGY
    11. Brizard, F; Brizard, A; Guilhot, F; Chomel, JC; Kitzis, A
      Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-alpha therapy or allogeneic bone marrow transplantation

      BLOOD
    12. Chomel, JC; Brizard, F; Veinstein, A; Rivet, J; Sadoun, A; Kitzis, A; Guilhot, F; Brizard, A
      Persistence of BCR-ABL genomic rearrangement in chronic myeloid leukemia patients in complete and sustained cytogenetic remission after interferon-alpha therapy or allogeneic bone marrow transplantation

      BLOOD
    13. Millot, F; Auriol, F; Brecheteau, P; Guilhot, F
      Acral erythema in children receiving high-dose methotrexate

      PEDIATRIC DERMATOLOGY
    14. Millot, F; Tailboux, L; Paccalin, M; Barret, D; Zelinsky, A; Thomas, E; Levillain, P; Guilhot, F
      Cat-scratch disease simulating a malignant process of the chest wall

      EUROPEAN JOURNAL OF PEDIATRICS
    15. Gahrton, G; Svensson, H; Bjorkstrand, B; Apperley, J; Carlson, K; Cavo, M; Ferrant, A; Fouillard, L; Gratecos, N; Gratwohl, A; Guilhot, F; Deliliers, GL; Ljungman, P; Masszi, T; Milligan, DW; Powles, RL; Reiffers, J; Samson, JD; Stoppa, AM; Vernant, JP; Volin, L; Wallvik, J
      Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation

      BONE MARROW TRANSPLANTATION
    16. Millot, F; Delval, O; Giraud, C; Bataille, B; Babin, P; Germain, T; Sadoun, A; Vandermarq, P; Guilhot, F
      High-dose chemotherapy with hematopoietic stem cell transplantation in adults with bone marrow relapse of medulloblastoma: report of two cases

      BONE MARROW TRANSPLANTATION
    17. Dhedin, N; Giraudier, S; Gaulard, P; Esperou, H; Ifrah, N; Michallet, M; Milpied, N; Rio, B; Cahn, JY; Molina, L; Laporte, JL; Guilhot, F; Kuentz, M
      Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database

      BRITISH JOURNAL OF HAEMATOLOGY
    18. Silver, RT; Woolf, SH; Hehlmann, R; Appelbaum, FR; Anderson, J; Bennett, C; Goldman, JM; Guilhot, F; Kantarjian, HM; Lichtin, AE; Talpaz, M; Tura, S
      An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: Developed for the American Society of Hematology

      BLOOD
    19. Facon, T; Harousseau, JL; Maloisel, F; Attal, M; Odriozola, J; Alegre, A; Schroyens, W; Hulin, C; Schots, R; Marin, P; Guilhot, F; Granena, A; De Waele, M; Pigneux, A; Meresse, V; Clark, P; Reiffers, J
      Stem cell factor in combination with filgrastim after chemotherapy improves peripheral blood progenitor cell yield and reduces apheresis requirementsin multiple myeloma patients: A randomized, controlled trial

      BLOOD
    20. Lacotte, L; Thierry, A; Delwail, V; Dreyfus, B; Guilhot, F
      Thrombotic thrombocytopenic purpura during interferon alpha treatment for chronic myelogenous leukemia

      ACTA HAEMATOLOGICA
    21. Guilhot, F
      Chronic myeloid leukaemia

      TEXTBOOK OF MALIGNANT HAEMATOLOGY
    22. GUILHOT F; LACOTTETHIERRY L
      INTERFERON-ALPHA - MECHANISMS OF ACTION IN CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE

      HEMATOLOGY AND CELL THERAPY
    23. ANDRIEU JM; JAIS JP; COLONNA P; DESABLENS B; BRIERE J; FRANCOIS S; HAROUSSEAU JL; CASASSUS P; LEMEVEL A; LEPRISE PY; GHANDOUR C; GUILHOT F; LEJEUNE F
      10-YEAR RESULTS OF A STRATEGY COMBINING 3 CYCLES OF ABVD AND HIGH-DOSE EXTENDED IRRADIATION FOR TREATING HODGKINS-DISEASE AT ADVANCED STAGES

      Annals of oncology
    24. BRIZARD F; CHOMEL JC; VEINSTEIN A; RIVET J; GIRAUD C; KITZIS A; GUILHOT F; BRIZARD A
      DOES BCR-ABL GENOMIC REARRANGEMENT PERSIST IN CML PATIENTS IN COMPLETE REMISSION AFTER INTERFERON-ALPHA THERAPY

      Leukemia
    25. DAHERON L; SALMERON S; PATRI S; BRIZARD A; GUILHOT F; CHOMEL JC; KITZIS A
      IDENTIFICATION OF SEVERAL GENES DIFFERENTIALLY EXPRESSED DURING PROGRESSION OF CHRONIC MYELOGENOUS LEUKEMIA

      Leukemia
    26. HAROUSSEAU JL; ATTAL M; PAYEN C; FACON T; MICHAUX JL; GUILHOT F; MONCONDUIT M; FUZIBET JG; CAILLOT D; DORVAUX V; CAHN JY; GROSBOIS B
      BONE-MARROW VERSUS PERIPHERAL-BLOOD VERSUS CD34-CELL FOR AUTOLOGOUS IN MULTIPLE-MYELOMA (MM)( PROGENITORS AS THE SOURCE OF STEM)

      Bone marrow transplantation
    27. ATTAL M; PAYEN C; FACON T; MICHAUX JL; GUILHOT F; MOCONDUIT M; FUZIBET JG; CAILLOT D; DORVAUX V; HAROUSSEAU JL; CAHN JY; GROBOIS B; STOPPA AM; IFRAH N; SOTTO JJ; PIGNON B; BATAILLE R
      SINGLE VERSUS DOUBLE TRANSPLANT IN MYELOMA - A RANDOMIZED TRIAL OF THE INTER-GROUPE-FRANCAIS-DU-MYELOME (IFM)

      Bone marrow transplantation
    28. SADOUN A; THIERRY A; GIRAUD C; BOIS M; DREYFUS B; GUILHOT F
      FILGRASTIM-PRIMED ALLOGENEIC BMT IN A REFRACTORY-ANEMIA WITH EXCESS BLASTS (RAEB) PATIENT

      Bone marrow transplantation
    29. GUILHOT F
      INTERFERON-ALPHA ALONE OR IN COMBINATION WITH CHEMOTHERAPY IN CHRONICMYELOID-LEUKEMIA (CML)

      British Journal of Haematology
    30. HAROUSSEAU JL; ATTAL M; PAYEN C; FACON T; MICHAUX JL; GUILHOT F; MONCONDUIT M; FUZIBET JG; CAILLOT D; DORVAUX V; CAHN JY; GROSBOIS B
      BONE-MARROW (BM) VERSUS PERIPHERAL-BLOOD VERSUS CD34-CELL FOR AUTOLOGOUS TRANSPLANTATION IN MULTIPLE-MYELOMA (MM)( PROGENITORS AS THE SOURCE OF STEM)

      British Journal of Haematology
    31. VILLARD F; BOHBOT A; BOUZGARROU R; CALOT JP; FEUGIER P; GIRAUD C; MALOISEL F; REIFFERS J; ATTAL M; WITZ F; GUILHOT F; HAROUSSEAU JL; MUR M; MERESSE V; CARAUX J; FACON T
      ADDITION OF SCF TO CHEMOTHERAPY AND FILGRASTIM MOBILIZATION MAY ENABLE PROGENITOR SUPPORT TO BE GIVEN IN THE FORM OF WHOLE-BLOOD INFUSIONS

      British Journal of Haematology
    32. HAROUSSEAU JL; FACON T; MALOISEL F; ATTAL M; ODRIOZOLA J; ALEGRE A; SCHROYENS W; HULIN C; MARIN P; SCHOTS R; GUILHOT F; GRANENA A; DEWAELE M; MERESSE V; REIFFERS J
      STEM-CELL FACTOR IN COMBINATION WITH FILGRASTIM FOLLOWING CHEMOTHERAPY IMPROVES PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION

      British Journal of Haematology
    33. TROUSSARD X; HENRYAMAR M; CARCEL C; BROUSTET A; MICHAUX JL; MALOISEL F; FEUGIER P; GUILHOT F; NOEL MP; GARDEMBAS M; FLANDRIN G
      LATE COMPLICATIONS IN PATIENTS WITH HAIRY-CELL LEUKEMIA TREATED WITH RECOMBINANT INTERFERON

      British Journal of Haematology
    34. DELWAIL V; BATAILLE B; INGRAND P; LAPIERRE F; GUILHOT F
      TREATMENT OF PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA - RESULTS OF THEFRENCH NEUROSURGICAL SOCIETY SERIES

      British Journal of Haematology
    35. GUILHOT F; MALOISEL F; GUERCI A; MICHALLET M; HAROUSSEAU JL; BRIERE J; ROCHANT H; CIURANA AJ; ABGRALL JF; GUYOTAT D; CHRISTIAN B; ORFEUVRE H
      UPDATE OF THE 810 CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED WITH INTERFERON-ALPHA-2B OR IFN ALPHA-2B AND CYTARABINE

      British Journal of Haematology
    36. MILLOT F; BRIZARD F; BABIN P; CANIONI D; MACINTYRE E; LEVARD G; GAMBERT C; RICOUR C; GUILHOT F
      T(3-17)(Q21-Q25) IN EPSTEIN-BARR-VIRUS ASSOCIATED PERIPHERAL T-CELL LYMPHOMA - A PEDIATRIC CASE

      British Journal of Haematology
    37. VEINSTEIN A; BRIZARD A; RANDRIAMALALA E; BABIN P; PREUDHOMME JL; GUILHOT F
      CENTRAL-NERVOUS-SYSTEM RELAPSES AFTER AUTOLOGOUS STEM-CELL TRANSPLANTATION FOR MYELOMA - REPORT OF 2 CASES

      HEMATOLOGY AND CELL THERAPY
    38. MILLOT F; KLOSSEK JM; BRIZARD F; BRIZARD A; VANDERMARQ P; BABIN P; GUILHOT F
      RECURRENCE OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA PRESENTING AS A TUMOR OF THE MIDDLE-EAR - A CASE-REPORT

      Journal of pediatric hematology/oncology
    39. BRIZARD F; DREYFUS B; GUILHOT F; TANZER J; BRIZARD A
      11Q13 REARRANGEMENT IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA

      Leukemia & lymphoma
    40. VEINSTEIN A; SADOUN A; BRIZARD A; CHOMIENNE C; GUILHOT F
      AUTOLOGOUS CD34 POSITIVE PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION FOR ACUTE PROMYELOCYTIC LEUKEMIA (APL) - REPORT OF A CASE

      Experimental hematology
    41. GUILHOT F; GUERCI A; MALOISEL F; MICHALLET M; HAROUSSEAU JL; BOUABDALLAH R; GUYOTAT D; ABGRALL JF; IFRAH N; BRIERE J; TERTIAN G; BAUTERS F; NAVARRO M; MORICE P; CHRISTINA B; VILQUE JM; BLANC M; CHASTANG C
      RELATIONSHIP BETWEEN CYTOGENETIC RESPONSE AND SURVIVAL IN CHRONIC MYELOGENOUS LEUKEMIA - RESULTS OF 2 MULTICENTRIC TRIALS

      Experimental hematology
    42. ARCHIMBAUD E; MICHALLET M; PHILIP L; CHARRIN C; CLAPISSON G; BELHABRI A; GUILHOT F; STRYCKMANS P; ADELEINE P; FIERE D
      G-CSF (FILGRASTIM) ADMINISTERED IN ADDITION TO INTERFERON-ALPHA (IF) TO MOBILIZE PERIPHERAL-BLOOD STEM-CELLS (PBSC) FOR AUTOLOGOUS TRANSPLANTATION IN CHRONIC MYELOID-LEUKEMIA (CML)

      Experimental hematology
    43. JOURDAN E; MARANINCHI D; REIFFERS J; GLUCKMAN E; RIO B; JOUET JP; MICHALLET M; MOLINA L; ARCHIMBAUD E; HAROUSSEAU JL; IFRAH N; ATTAL M; GUILHOT F; KUENTZ M; GUYOTAT D; PICO JL; DAURIAC C; LEGROS M; DREYFUS F; BORDIGONI P; LEBLOND V; GRATECOS N; VARET B; AUZANNEAU C; TILLY H; VILMER E; BARDOU VJ; BLAISE D
      EARLY ALLOGENEIC TRANSPLANTATION FAVORABLY INFLUENCES THE OUTCOME OF ADULT PATIENTS SUFFERING FROM ACUTE MYELOID-LEUKEMIA

      Bone marrow transplantation
    44. SADOUN A; LACOTTE L; DELWAIL V; RANDRIAMALALA E; PATRI S; BABIN P; BRIZARD A; GUILHOT F
      ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR HYPEREOSINOPHILIC SYNDROMEWITH ADVANCED MYELOFIBROSIS

      Bone marrow transplantation
    45. GUILHOT F
      INTRON-A AND CYTOSINE-ARABINOSIDE IN THE TREATMENT OF CHRONIC MYELOID-LEUKEMIA - RATIONALE AND PILOT RESULTS

      Gematologia i transfuziologia
    46. MILLOT F; ROBERT A; BERTRAND Y; MECHINAUD F; LAUREYS G; FERSTER A; BROCK P; ROHRLICH P; MAZINGUE F; PLANTAZ D; PLOUVIER E; PACQUEMENT H; BEHAR C; RIALLAND X; CHANTRAINE JM; GUILHOT F; OTTEN J
      CUTANEOUS INVOLVEMENT IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA OR LYMPHOBLASTIC LYMPHOMA

      Pediatrics
    47. GUILHOT F; CHASTANG C; MICHALLET M; GUERCI A; HAROUSSEAU JL; MALOISEL F; BOUABDALLAH R; GUYOTAT D; CHERON N; NICOLINI F; ABGRALL JF; TANZER J
      INTERFERON ALFA-2B COMBINED WITH CYTARABINE VERSUS INTERFERON ALONE IN CHRONIC MYELOGENOUS LEUKEMIA

      The New England journal of medicine
    48. GUILHOT F; GUILHOT J; CHASTANG C
      INTERFERON ALFA-2B AND CYTARABINE IN CHRONIC MYELOGENOUS LEUKEMIA - REPLY

      The New England journal of medicine
    49. ARCHIMBAUD E; MICHALLET M; PHILIP I; CHARRIN C; CLAPISSON G; BELHABRI A; GUILHOT F; STRYCKMANS P; ADELEINE P; FIERE D
      GRANULOCYTE-COLONY-STIMULATING FACTOR GIVEN IN ADDITION TO INTERFERON-ALPHA TO MOBILIZE PERIPHERAL-BLOOD STEM-CELLS FOR AUTOLOGOUS TRANSPLANTATION IN CHRONIC MYELOID-LEUKEMIA

      British Journal of Haematology
    50. HAROUSSEAU JL; CAHN JY; PIGNON B; WITZ F; MILPIED N; DELAIN M; LIOURE B; LAMY T; DESABLENS B; GUILHOT F; CAILLOT D; ABGRALL JF; FRANCOIS S; BRIERE J; GUYOTAT D; CASASSUS P; AUDHUY B; TELLIER Z; HURTELOUP P; HERVE P
      COMPARISON OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION AND INTENSIVE CHEMOTHERAPY AS POSTREMISSION THERAPY IN ADULT ACUTE MYELOID-LEUKEMIA

      Blood
    51. DASCALESCU CM; CHOMEL JC; BOUILLY I; CHAUVET M; SOTTO MF; GUILHOT J; RIVET J; SOTTO JJ; KITZIS A; GUILHOT F
      PROPOSAL OF A SCORING SYSTEM FOR RESPONSIVENESS TO INTERFERON-ALPHA AT DIAGNOSIS IN CHRONIC MYELOGENOUS LEUKEMIA

      Blood
    52. HAROUSSEAU JL; ATTAL M; PAYEN C; FACON T; MICHAUX JL; GUILHOT F; MOCONDUIT M; FUZIBET JG; CAILLOT D; DORVAUX V; CAHN JY; GROBOIS B; STOPPA AM; IFRAH N; SOTTO JJ; PIGNON B; BATAILLE R
      BONE-MARROW VERSUS BLOOD AS SOURCE OF HEMATOPOIETIC STEM-CELLS AFTER HIGH-DOSE THERAPY IN MULTIPLE-MYELOMA - A PROSPECTIVE, RANDOMIZED STUDY OF THE INTERGROUPE-FRANCAIS-DU-MYELOME (IFM)

      Blood
    53. ATTAL M; PAYEN C; FACON T; MICHAUX JL; GUILHOT F; MOCONDUIT M; FUZIBET JG; CAILLOT D; DORVAUX V; HAROUSSEAU JL; CAHN JY; GROBOIS B; STOPPA AM; IFRAH N; SOTTO JJ; PIGNON B; BATAILLE R
      SINGLE VERSUS DOUBLE TRANSPLANT IN MYELOMA - A RANDOMIZED TRIAL OF THE INTER-GROUPE-FRANCAIS-DU-MYELOME (IFM)

      Blood
    54. GUILHOT F; GUERCI A; MALOISEL F; HAROUSSEAU JL; BRIERE J; IFRAH N; ABGRALL JF; GUYOTAT D; CHRISTIAN B; BAUDUER F; JAUBERT D; MARTIN C; GUILHOT J; CHASTANG C
      FOLLOW-UP OF 1047 PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA, TREATEDWITH INTERFERON OR INTERFERON AND CYTARABINE

      Blood
    55. PATRI S; DASCALESCU C; CHOMEL JC; SADOUN A; LACOTTE L; TANZER J; GUILHOT F; KITZIS A
      MONITORING AND PROGNOSTIC EVALUATION OF SEX-MISMATCHED BONE-MARROW TRANSPLANTATION BY COMPETITIVE PCR ON Y-CHROMOSOME SEQUENCES

      Bone marrow transplantation
    56. GUILHOT F; GUERCI A; FIERE D; HAROUSSEAU JL; MALOISEL F; BOUABDALLAH R; GUYOTAT D; ROCHANT H; NAJMAN A; NICOLINI F; COLOMBAT P; ABGRALL JF; IFRAH N; BRIERE J; BAUTERS F; NAVARRO M; MORICE P; BORDESSOULE D; VILQUE JP; DESABLENS B; TERTIAN G; BLANC M; CHASTANG C; TANZER J
      THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA BY INTERFERON AND CYTOSINE-ARABINOSIDE - RATIONAL AND DESIGN OF THE FRENCH TRIALS

      Bone marrow transplantation
    57. HEIMPEL H; ALLAN NC; BACCARANI M; GUILHOT F; HEHLMANN R; HOROWITZ M; KLUINNELEMANS J; SCHAEFER U; STORB R; THALER J
      CURRENT CONTROVERSIES ON THE ROLE OF INTERFERON-ALPHA FOR THERAPY OF CHRONIC MYELOID-LEUKEMIA

      Bone marrow transplantation
    58. CABALLERO E; GUILHOT F; LOPEZ JL; MEDARDE M; SAHAGUN H; TOME F
      SYNTHESIS AND DIELS-ALDER REACTIVITY OF SIMPLE 1-PHENOXY-1,3-DIENES

      Tetrahedron letters
    59. NEAU JP; GUILHOT F; BOINOT C; DUMAS P; TANTOT AM; GIL R
      DEVELOPMENT OF CHOREA WITH LUPUS ANTICOAGULANT AFTER INTERFERON THERAPY

      European neurology
    60. GUILHOT F; CHASTANG C; GUERCI A; MICHALLET M; HAROUSSEAU JL; MALOISEL F; BRIERE J; BOUABDALLAH R; GUYOTAT D; TERTIAN G; NICOLINI F; ABGRALL JF; NAVARRO M; BLANC M; BRICE P; SIMON M; IFRAH N; ROCHANT F; VILQUE JP; DELAIN M; GUILHOT J; TANZER J
      INTERFERON ALPHA2B (IFN) AND CYTARABINE (ARA-C) SURVIVAL AND CYTOGENETIC RESPONSE IN CHRONIC LEUKEMIA (CML) - RESULTS OF A RANDOMIZED TRIAL

      Blood
    61. DAHERON L; PATRI S; GUILHOT F; SALMERON S; CHOMEL JC; KITZIS A
      IDENTIFICATION OF GENES DIFFERENTIALLY EXPRESSED DURING PROGRESSION OF CHRONIC MYELOGENOUS LEUKEMIA (CML)

      Blood
    62. KATTAN MW; INOUE Y; GILES FJ; TALPAZ M; OZER H; GUILHOT F; ZUFFA E; HUBER SL; BECK JR
      COST-EFFECTIVENESS OF INTERFERON-ALPHA AND CONVENTIONAL CHEMOTHERAPY IN CHRONIC MYELOGENOUS LEUKEMIA

      Annals of internal medicine
    63. LACOTTE L; DELWAIL V; SADOUN A; DREYFUS B; BRIZARD A; BABIN P; GUILHOT F
      HYPERCALCEMIA IN PRIMARY HYPEREOSINOPHILI A SYNDROME

      Annales de medecine interne
    64. JOURDAN E; MARANINCHI D; REIFFERS J; ARCHIMBAUD E; MICHALLET M; HAROUSSEAU JL; IFRAH N; RIO B; GUYOTAT D; GUILHOT F; ATTAL M; LEBLOND V; DAURIAC C; LEGROS M; PICO JL; MARIT G; BLAISE D
      ALLOGENEIC BONE-MARROW TRANSPLANTATION REMAINS AN EFFICIENT CONSOLIDATION FOR ADULTS WITH ACUTE MYELOID-LEUKEMIA EVEN WHEN PERFORMED VERY SOON AFTER DIAGNOSIS (LESS-THAN-100 DAYS)

      Leukemia
    65. CHOMEL JC; GUILHOT F; TANZER J; KITZIS A
      MOLECULAR DEREGULATIONS MEDIATED BY BCR-A BL IN CHRONIC MYELOID-LEUKEMIA

      MS. Medecine sciences
    66. SADOUN A; DEBOUCHONY ET; GIRAUD C; DREYFUS B; RANDRIAMALALA F; BRIZARD A; ALCALAY D; GUILHOT F
      OPTIMIZING FACTORS FOR HEMATOLOGICAL RECOVERY AFTER AUTOLOGOUS CD34 POSITIVE PERIPHERAL-BLOOD STEM-CELLS (PBSC) TRANSPLANTATION

      Experimental hematology
    67. PIGNEUX A; DEVERGIE A; POCHITALOFF M; RIO B; ARCHIMBAUD E; CAHN JY; LEBLOND V; MICHALLET M; JOUET JP; GUILHOT F; GLUCKMAN E; REIFFERS J
      RECOMBINANT ALPHA-INTERFERON AS TREATMENT FOR CHRONIC MYELOGENOUS LEUKEMIA IN RELAPSE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION - A REPORT FROM THE SOCIETE-FRANCAISE-LE-GREFFE-DE-MOELLE

      Bone marrow transplantation
    68. MAHDI T; TANZER J; BRIZARD A; GUILHOT F; BABIN P; KITZIS A
      CELL-MEDIATED CYTOTOXICITY CAN BE REGULATED BY P53 TUMOR-SUPPRESSOR GENE ACTIVITY IN-VITRO

      Biology of the cell
    69. MILLOT F; DHONDT JL; MAZINGUE F; MECHINAUD F; INGRAND P; GUILHOT F
      CHANGES OF CEREBRAL BIOPTERIN AND BIOGENIC-AMINE METABOLISM IN LEUKEMIC CHILDREN RECEIVING 5G M(2) INTRAVENOUS METHOTREXATE/

      Pediatric research
    70. LONGREE L; PAUTIER P; GUILHOT F; BRICE P
      PREGNANCY OCCURRING DURING COMPLETE CYTOGENETIC RESPONSE AFTER INTERFERON THERAPY IN CHRONIC MYELOID-LEUKEMIA

      Nouvelle revue francaise d'hematologie
    71. MILLOT F; ROBERT A; BERTRAND Y; MECHINAUD F; LAUREYS G; FERSTER A; BROCK P; RORLICH P; MAZINGUE F; PLANTZ D; PACQUEMENT H; BEHAR C; RIALLAND X; CHANTRAINE JM; TOKAJI E; GUILHOT F
      SPECIFIC CUTANEOUS INFILTRATES IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA OR LYMPHOBLASTIC LYMPHOMA

      Blood
    72. HAROUSSEAU JL; FACON T; MALOISEL F; DABOUZHARROUCHE F; WITZ F; GUILHOT F; ARCHIMBAUD E; DESABLENS B; ABGRALL JF; LINASSIER C; GROSBOIS B; BANCILLON A; BADRI N; BATAILLE R
      G-CSF INSTEAD OF AUTOLOGOUS STEM-CELL TRANSPLANTATION AFTER HIGH-DOSEMELPHALAN AS FRONT-LINE THERAPY IN MULTIPLE-MYELOMA

      Blood
    73. GUILHOT F; DELWAIL V; LACOTTE L; BRIZARD A; CHOMEL JC; KITZIS A
      LYMPHOID BLAST CRISIS IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN COMPLETE CYTOGENETIC REMISSION AFTER INTERFERON THERAPY

      Blood
    74. BRIZARD F; BRIZARD A; DREYFUS B; GUILHOT F; TANZER J
      11Q13 REARRANGEMENT IN B-CELL CHRONIC LYMPHOID LEUKEMIA (B-CLL)

      Blood
    75. FENAUX P; MOREL P; BAUTERS F; PIGUET H; MONCONDUIT M; TILLY F; DESABLENS B; CLAISSE JF; ADJIZIAN JC; POTRON G; PIGNON B; LEPORRIER M; TROUSSARD X; REMAN O; BINET JL; DIGHIERO G; MALOUM K; MERLEBERAL H; RAPHAEL M; REISENLEITER M; LINASSIER C; LAMAGNERE JP; JAUBERT J; VASSELOM C; LEBLAY R; JACOMY D; GROSBOIS B; DREYFUS B; GUILHOT F; VAUGIER G; SOUTEYRAND P; LEPEU G; TOUCHAIS AM; BOUDJERRA N; BORDESSOULE M; SCHMIDT J; FACQUETDANIS J; SEBBAN C; ALLARD C; MURGUE B; SCHVED JF; ARNAUD A; CASSASSUS P; LEPRISE PY; DOR JF; TURPIN F; SOLALCELIGNY P; TERTIAN G; BERNARD JF; JAMES JM; REIGNER A; BLANC M; RAPP MJ; BOURGEOIS JP; LEJEUNE F; SALLES B; RENOUX M; GARIN B; CAMO J; TCHERNIA G; CECCALDI J; DEVIDAS A; LEMEVELLEPOURHIET A; BRIERE J; JANVIER M; NAJEAN Y; CHEVRET S; CHASTANG C; TRAVADE P
      IS THE CHOP REGIMEN A GOOD TREATMENT FOR ADVANCED CLL - RESULTS FROM 2 RANDOMIZED CLINICAL-TRIALS

      Leukemia & lymphoma
    76. BRIZARD A; BRIZARD F; BABIN P; AGIUS G; DELWAIL V; GUILHOT F; TANZER J
      UNCLASSIFIABLE HIGH-GRADE MALIGNANT T-CELL LYMPHOMA WITH CLONAL EVOLUTION

      Leukemia & lymphoma
    77. BRIZARD F; BRIZARD A; GUILHOT F; TANZER J; BERGER R
      DETECTION OF MONOSOMY-7 AND TRISOMY-8 AND TRISOMY-11 IN MYELODYSPLASTIC DISORDERS BY INTERPHASE FLUORESCENT IN-SITU HYBRIDIZATION - COMPARISON WITH ACUTE NONLYMPHOCYTIC LEUKEMIAS

      Leukemia
    78. TRON E; BRIZARD A; SADOUN A; GIRAUD C; RANDRIAMALALA E; DELWAIL V; DREYFUS B; ALCALAY D; GUILHOT F; DELAFOREST GP
      CYTOMETRY GUIDELINES FOR BLOOD CD34- ONE-CENTER EXPERIENCE( CONCENTRATION )

      Experimental hematology
    79. SADOUN A; PATRI S; DELWAIL V; CHOMEL JC; COGNE M; BRIZARD A; KITZIS A; GUILHOT F
      MOLECULAR REMISSION AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC-LEUKEMIA

      Bone marrow transplantation
    80. MOSSAFA H; HURET JL; BRIZARD A; GUILHOT F; LESSARD M; TANZER J
      ISOCHROMOSOME 8Q - A NEW RECURRING SECONDARY ANOMALY IN ADULTS WITH B-LINEAGE ACUTE LYMPHOID LEUKEMIA

      Cancer genetics and cytogenetics
    81. GUILHOT F
      THE ROLE OF INTERFERON IN THE TREATMENT OF CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE

      Nouvelle revue francaise d'hematologie
    82. MOSSAFA H; BRIZARD A; HURET JL; BRIZARD F; LESSARD M; GUILHOT F; TANZER J
      TRISOMY 8Q DUE TO I(8Q) OR DER(8) T(88) IS A FREQUENT LESION IN T-PROLYMPHOCYTIC LEUKEMIA - 4 NEW CASES AND A REVIEW OF THE LITERATURE

      British Journal of Haematology
    83. MAHDI T; ALCALAY D; BRIZARD A; KITZIS A; GUILHOT F; TANZER J
      IN-VITRO TREATMENT WITH P53 AND OR RB ANTISENSE (AS) OLIGODEOXYNUCLEOTIDES IN ASSOCIATION WITH GROWTH-FACTORS (GF) INDUCES PROLIFERATION OFNORMAL HUMAN PERIPHERAL-BLOOD STEM-CELLS

      Blood
    84. GUILHOT F; SCHUESSLER M; RAPP MJ; HAROUSSEAU JL; FIERE D
      CYTOGENETICS RESPONSES IN CML PATIENTS TREATED WITH A DAILY ORALLY ARA-C PRODRUG YNKOI - A PHASE-I II TRIAL/

      Blood
    85. JOURDAN E; BLAISC D; REIFFERS J; GLUCKMAN E; RIO B; JOUET JP; MICHALLET M; ARCHIMBAUD E; HAROUSSEAU JL; IFRAH N; ATTAL M; GUILHOT F; KUENTZ M; GUYOTAT D; PICO JL; DAURIAC C; LEGROS M; DREYFUS F; BORDIGONI P; LEBLOND V; GRATECOS N; VARET B; AUZANNCAU C; TILLY H; VILMER E; MARANINCHI D
      ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR ADULT WITH ACUTE MYELOID-LEUKEMIA IN 1ST COMPLETE REMISSION - A REPORT FROM THE SOCIETE-FRANCAISE-DE-GREFFE-DE-MOELLE

      Blood
    86. PATRI S; SADOUN A; DASCALESCU C; CHOMEL JC; TANZER J; GUILHOT F; KITZIS A
      FOLLOW-UP AND EVOLUTION PREDICTION OF BONE-MARROW TRANSPLANTATION BY COMPETITIVE PCR ON Y-CHROMOSOME SEQUENCES

      Blood
    87. GUILHOT F; ABGRALL JF; HAROUSSEAU JL; BAUTERS F; BRICE P; DINE G; TILLY H; IFRAH N; CASSASUS P; ROCHANT H; CHRISTIAN B; GUERCI A; LAMAGNERE JP; LEPRISE PY; DUCLOS B; TANZER J
      A MULTICENTRIC RANDOMIZED STUDY OF ALPHA-2B INTERFERON (IFN) AND HYDROXYUREA (HU) WITH OR WITHOUT CYTOSINE-ARABINOSIDE (ARA-C) IN PREVIOUSLY UNTREATED PATIENTS WITH PH-LEUKEMIA (CML) - PRELIMINARY CYTOGENETIC RESULTS( CHRONIC MYELOCYTIC)

      Leukemia & lymphoma
    88. BINET JL; FENAUX P; MOREL P; BAUTERS F; PIGUET H; MONCONDUIT M; TILLY F; DESABLENS B; CLAISSE JF; ADJIZIAN JC; POTRON G; PIGNON B; LEPORRIER M; TROUSSARD X; REMAN O; BINET JL; MALOUM K; MERLEBERAL H; RAPHAEL M; REISENLEITER M; LINASSIER C; LAMAGNERE JP; JAUBERT J; VASSELOM C; LEBLAY R; JACOMY D; GROSBOIS B; DREYFUS B; GUILHOT F; VAUGIER G; SOUTEYRAND P; LEPEU G; TOUCHIAS AM; BOUDJERRA N; BORDESSOULE M; TRAVADE P; SCHMIDT J; FACQUETDANIS J; SEBBAN C; ALLARD C; ROUSSET T; NAVARRO M; SCHVED JF; ARNAUD A; CASASSUS P; LEPRISE PY; DOR JF; TURPIN F; SOLALCELIGNY P; TERTIAN G; BERNARD JF; JAMES JM; REIGNER A; BLANC M; RAPP MJ; BOURGEOIS JP; LEJEUNE F; SALLES B; RENOUX M; GARIN B; CAMP J; TCHERNIA G; CECCALDI J; DEVIDAS A; LEMEVELLEPOURHIET A; BRIERE J; JANVIER M; NAJEAN Y; KERNEIS Y; COIFFIE B; DIGHIERO G; TEILLET F; GARNIER; DOIRON; STOPPA; ROGE; MAIGRE M; MAISONNEUVE; DIVINE M; CHERON; RODON; SIMON; THYSS; BRION A; EGHBALI; CHRISTIAN; CARDE; AUTRAND; PAITEL; SELIGMANN M; VIGNERON
      TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA

      Bailliere's clinical haematology
    89. SADOUN A; DURIEZ P; DELWAIL V; LEVILLAIN P; LACROIX C; GUILHOT F
      CUTANEOUS ASPERGILLOSIS ASSOCIATED WITH ANTIGENEMIA IN A CASE OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION

      Medecine et maladies infectieuses
    90. MOREL F; DELWAIL V; BRIZARD A; MESERI A; GUILHOT F; DELAFOREST PG; LECRON JC
      EFFECTS OF SCD23 ON PROLIFERATION OF LEUKEMIC-CELLS FROM A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA DURING BLAST CRISIS

      American journal of hematology
    91. BOINOT C; GUICHETOT M; GUILHOT F; MAHON FX; SADOUN A; TANZER J; SULTAN Y
      ANTIPHOSPHOLIPID ANTIBODIES (LA) IN PATIENTS TREATED WITH RECOMBINANTINTERFERON

      Thrombosis and haemostasis
    92. PIGNEUX A; REIFFERS J; DEVERGIE A; LAFAGE M; RIO B; ARCHIMBAUD E; CAHN JY; LEBLOND V; MICHALLET M; GUILHOT F; GLUCKMAN E
      RECOMBINANT ALPHA-INTERFERON AS TREATMENT FOR RELAPSED CHRONIC MYELOGENOUS LEUKEMIA AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Experimental hematology
    93. MESERIDELWAIL A; DELWAIL V; BRIZARD A; GUILHOT F; LECRON JC; DELAFOREST PG
      STUDIES OF LAK CELL CYTOTOXICITY FOR NORMAL AND CHRONIC MYELOGENOUS LEUKEMIA (CML) BONE-MARROW CFU-GM

      Experimental hematology
    94. DELWAIL V; SADOUN A; DEPAILLETTE DE; LEGERPICHERIT E; CARDE P; GUILHOT F
      UNEXPECTED APPARENT COMPLETE REMISSION IN A NON-HODGKINS-LYMPHOMA PATIENT TREATED BY AC-SDKP AND CYTOSINE-ARABINOSIDE (CA)

      Experimental hematology
    95. GUILHOT F
      INTERFERON-ALFA AND LOW-DOSE CYTOSINE-ARABINOSIDE FOR THE TREATMENT OF PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE

      Seminars in hematology
    96. GUILHOT F
      TREATMENT OF CHRONIC MYELOID-LEUKEMIA

      Nouvelle revue francaise d'hematologie
    97. GUILHOT F; CHOMEL JC; BRIZARD A; KITZIS A; TANZER J
      POSITIVE POLYMERASE CHAIN-REACTION (PCR) IN CML PATIENTS WITH PROLONGED COMPLETE CYTOGENETIC RESPONSES INDUCED BY INTERFERON

      Blood
    98. BRIZARD A; LESSARD M; BRIZARD F; VALENSI F; JAOUEN E; GUILHOT F; FLANDRIN G; TANZER J
      HAIRY-CELL LEUKEMIA VARIANT (HCL-V) - CHROMOSOMAL-ANOMALIES IN 2 PATIENTS

      Blood
    99. GUILHOT F; SADOUN A; DELWAIL V
      TREATMENT OF MALIGNANT HEMOPATHIES WITH I NTERFERONS

      Annales de medecine interne


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/10/20 alle ore 06:27:02